Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 30, 2017
Center for Drug Evaluation and Research
15016857-1152-47bd-87a5-412d726e1dfc
Related Documents
Study and Evaluation of Sex Differences in the Clinical Evaluation of Drugs: Guidance for Industry
Guidance DocumentJuly 22, 1993
Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products: Guidance for Industry
Guidance DocumentDecember 6, 2012
ICH Q3C Maintenance Procedures for the Guidance for Industry Q3C Impurities: Residual Solvents
Guidance DocumentJuly 25, 2017
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.